Member Societies

• All
• 298
• 299
• 300

Symposium 21 (KASID) : Recent Advances in Early Detection & Prevention of Colorectal Cancer English

Date / Time	299,
Channel
Speakers	15:55-16:15	Conventional methods for detection of colorectal cancer: Are they enough?
	16:15-16:35	Up to date biomarkers for detecting colorectal cancer
	16:35-16:55	Early diagnosis and prediction of prognosis of colorectal cancer using microbiome
	16:55-17:15	Nutritional aspect in the prevention of colorectal cancer
	17:15-17:25	Discussion

Symposium 14 (KSG) : Future Diagnosis of Gastrointestinal Disease: Biomarkers and Beyond English

Date / Time	299,
Channel
Speakers	08:30-08:52	An integrative approach to cancer based on precision medicine
	08:52-09:14	Biomarkers in the diagnosis of gastric cancer
	09:14-09:36	Proteomics for PIVKA-II in HCC surveillance
	09:36-09:58	Esophageal impedance test: A new diagnostic approach for GERD and functional esophageal disorder

Symposium 16 (KSG) : The Evolution of Personalized Medicine in Gastroenterology English

Date / Time	299,
Channel
Speakers	10:15-10:37	Tailored therapy for refractory Helicobacter pylori infection
	10:37-10:59	Personalized therapeutic approach to inflammatory bowel disease
	10:59-11:21	State of the art for liquid biomarkers in pancreatic cancer: An important consideration in the era of precision oncology
	11:21-11:43	The emerging role of liquid biopsy in digestive cancer

Big Data Session 02 (KSG) : Using Big Data to Discover Diagnostics and Therapeutics for GI Diseases English

Date / Time	299,
Channel
Speakers	12:25-12:47	Big data research in IBD: From real world data to real world evidence
	12:47-13:09	Deep dive into bioinformatics in gastrointestinal cancer
	13:09-13:31	Development of therapeutic decision model in hepatology using artificial intelligence
	13:31-13:53	Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning

Basic/Translational Symposium 03 (KSG) : Exploring a New Way Out Using Novel Molecule and Cell Therapy in GI Cancer English

Date / Time	299,
Channel
Speakers	14:10-14:32	Early detection and stratification of gastric cancer through stem cell marker and miRNA
	14:32-14:54	Overcoming peritoneal metastasis of colon cancer with STING-based immunotherapy
	14:54-15:16	Anti-tumor therapy of HCC using CAR T Cells derived from iPS cell
	15:16-15:38	Nano-bio system for the capture of pancreatic cancer cell secreted exosomes

Symposium 22 (Insurance Policy Session) Korean

Date / Time	299,
Channel
Speakers	15:55-16:20	Changes in Korea's healthcare system and tasks of academic society in times of the COVID-19 Pandemic (코로나 이후 보건의료환경 변화와 학회의 대응)
	16:20-16:40	Current status and future directions of review and assessment for gastrointestinal disease (소화기 질환의 심사 현황과 향후 방향)
	16:40-17:00	Necessity and prospect of reimbursement for magnifying endoscopy (확대 내시경 급여 필요성과 전망)
	17:00-17:25	Payment systems of health care: From the fee-for-service to various payment systems (행위별 수가제도에서 다양한 지불제도로)

Combined Symposium 04 (KSG+KSGE) : Endoscopy in Functional GI Disorders English

Date / Time	299,
Channel
Speakers	08:30-08:52	The role of endoscopy in achalasia
	08:52-09:14	The role of endoscopy and biopsy in chronic diarrhea with IBS-D
	09:14-09:36	The role of endoscopy in intestinal pseudo-obstruction, adult Hirschsprung's disease
	09:36-09:58	Anti-reflux endoscopic surgery for Gastroesophageal Reflux Disease

Combined Symposium 05 (KSG+KASID) : Immunity and Microbiome in the Gut English

Date / Time	299,
Channel
Speakers	10:15-10:37	The microbiota of early life and developmental immunology
	10:37-10:59	The effect of immunologic factors in IBS
	10:59-11:21	Microbial modulation of inflammation in IBD
	11:21-11:43	Immune response and gut microbiome in colorectal cancer

Symposium 18 (KSG) : Recent Update for Autoimmune Gastrointestinal Diseases English

Date / Time	299,
Channel
Speakers	12:25-12:47	Classification criteria for IgG4-related disease
	12:47-13:09	Second line management of autoimmune hepatitis
	13:09-13:31	Novel immune therapy in IBD
	13:31-13:53	Novel therapy in primary sclerosing cholangitis

Combined Symposium 07 (KSG+KSGC) : Molecular Classification & Actionable Gene Mutations in GI Cancer English

Date / Time	299,
Channel
Speakers	14:10-14:32	Gastric cancer
	14:32-14:54	Colon cancer
	14:54-15:16	Hepatocellular carcinoma
	15:16-15:38	Pancreatic cancer

KASL-AASLD Joint Symposium 02 (KASL) : Recent Update of Fatty Liver Disease English

Date / Time	299,
Channel
Speakers	10:15-10:45	A unique phenotype of NAFLD: NAFLD with sarcopenia
	10:45-11:15	Recent updates of clinical trials on NASH
	11:15-11:45	Influence of NAFLD on chronic hepatitis B and C

KASL-AASLD Joint Symposium 01 (KASL) : COVID-19 and the Management of Chronic Liver Diseases English

Date / Time	299,
Channel
Speakers	08:30-09:00	Pathogenesis and outcomes of COVID-19 in patients with chronic liver disease
	09:00-09:30	COVID-19 in liver transplantation
	09:30-10:00	COVID-19 vaccination for patients with chronic liver diseases

KASL-AASLD Joint Symposium 03 (KASL) : Changes in the Management of Chronic Hepatitis B English

Date / Time	299,
Channel
Speakers	12:25-12:55	Artificial intelligence-driven HCC prediction model for patients with chronic hepatitis B
	12:55-13:25	Expanding treatment criteria for chronic hepatitis B
	13:25-13:55	Recent updates of clinical trials on functional cure of chronic hepatitis B

Basic/Translational Symposium 04 (KASL) : Basic Science Forum of Liver Disease: Metabolic Approaches for the Translational Medicine of Liver Diseases English

Date / Time	299,
Channel
Speakers	14:10-14:32	Small intestinal dietary fructose metabolism prevents non-alcoholic fatty liver disease
	14:32-14:54	Microbial metabolites entering into the liver: The role in diabetes and drug responses
	14:54-15:16	Fructose modulates leaky gut, endotoxemia and liver fibrosis through CYP2E1-mediated oxidative and Nitrative stress
	15:16-15:38	Role of diabetes on the risk of hepatocellular carcinoma in cirrhosis patients with NAFLD

Multidisciplinary Session 02 (KASL) : Comprehensive Multidisciplinary Approach for Obesity and/or NAFLD Korean

Date / Time	299,
Channel
Speakers	15:55-16:17	Clinical significance of obese and non-obese Fatty Liver Disease
	16:17-16:39	Radiological assessment of NAFLD
	16:39-17:01	Endoscopic therapies for obesity in NAFLD
	17:01-17:23	Bariatric surgery in the management of obesity in NAFLD

Symposium 20 (Abdominal USG Training Specialist 1) : Session 1 for Abdominal USG Training Specialist Korean

Date / Time	299,
Channel
Speakers	14:10-14:32	Abdominal ultrasound training know-how for internal medicine residents and gastroenterology fellows
	14:32-14:54	Quality assurance in abdominal ultrasonography: Suggestion for certification of excellent ultrasound center
	14:54-15:16	A new horizon of ultrasound training for residents - POCUS
	15:16-15:40	Experience in operating ultrasound hands-on programs for internal medicine residents - Cardiology

Symposium 23 (Abdominal USG Training Specialist 2) : Session 2 for Abdominal USG Training Specialist Korean

Date / Time	299,
Channel
Speakers	15:55-16:17	Ultrasound exam tips to reduce blind spots
	16:17-16:39	Understandings for lower abdominal and kidney ultrasound
	16:39-17:01	Interesting ultrasound cases of pancreas cystic lesions
	17:01-17:25	Interesting ultrasound cases of hepatic tumors

Symposium 15 (KPBA) : How to Improve the Survival of Patients with Pancreatic Cancer English

Date / Time	299,
Channel
Speakers	08:30-08:52	High risk population for pancreatic cancer
	08:52-09:14	Second-line chemotherapy for advanced pancreatic cancer
	09:14-09:36	Emerging molecular targets in pancreatic cancer
	09:36-09:58	Real-world data on the survival of patients with pancreatic cancer in Korea

Symposium 17 (KPBA) : Endoscopic Management of Acute Pancreatitis and Its Complications English

Date / Time	299,
Channel
Speakers	10:15-10:37	Indication, timing and safe technique of early/urgent ERCP in acute pancreatitis
	10:37-10:59	EUS guided transmural drainage for pancreatitis related local complications
	10:59-11:21	Endoscopic transluminal necrosectomy for complicated walled off necrosis
	11:21-11:43	Risk and benefit of ERCP in pancreatitis related complications: Leakage, stricture and disconnection

Combined Symposium 06 (KPBA+KSGE) : Innovations in Diagnostic and Therapeutic Endoscopy for Pancreatic Neoplasm English

Date / Time	299,
Channel
Speakers	12:25-12:47	How to maximize the effect of RFA for pancreatic tumor
	12:47-13:09	The way to go more productive EUS-FNB
	13:09-13:31	The new era of EUS-guided diagnosis of pancreatic cyst
	13:31-13:53	Early diagnosis for pancreatic cancer

PG Course 04 (KCHUGR) : Up-to-date Issues of Peptic Ulcer Disease Korean

Date / Time	299,
Channel
Speakers	15:55-16:17	Strategy for treatment of recurrent peptic ulcer
	16:17-16:39	Risk factors of peptic ulcer bleeding
	16:39-17:01	Strategy for treatment of peptic ulcer bleeding
	17:01-17:23	Effect of Helicobacter pylori eradication in peptic ulcer

PG Course 01 (KSGC) : Practical Guidance for the Improvement of QOL in GI Cancer Korean

Date / Time	299,
Channel
Speakers	08:30-08:52	Malignant bowel obstruction due to advanced GI cancer: Diagnosis and management
	08:52-09:14	Breakthrough pain in GI cancer patients: Assessment and management
	09:14-09:36	Sleep disturbance in GI cancer patients: Assessment and management
	09:36-09:58	Caregiver in GI cancer patients: Important roles, burden and support

PG Course 02 (KSNM) : A to Z of GERD Korean

Date / Time	299,
Channel
Speakers	10:15-10:35	Pathophysiology
	10:35-10:55	Diagnostic approach
	10:55-11:15	Medical treatment
	11:15-11:35	Surgical treatment
	11:35-11:45	Discussion

Symposium 19 (KSNM) : Achalasia: 2021 Updates Korean

Date / Time	299,
Channel
Speakers	12:25-12:45	Pathophysiology
	12:45-13:05	Diagnostic approach
	13:05-13:25	Overview of currently available therapeutic options
	13:25-13:45	Seoul consensus
	13:45-13:55	Discussion

PG Course 03 (KPBA) : All about Medical Management of Pancreatobiliary Diseases Korean

Date / Time	299,
Channel
Speakers	14:10-14:32	IV hydration and protease inhibitors in acute pancreatitis
	14:32-14:54	Bile acids in gallstones
	14:54-15:16	Antibiotics in acute cholangitis and cholecystitis
	15:16-15:38	Steroid and immunosuppressants in autoimmune pancreatitis